The present disclosure is directed to antibodies specific to carbamazepine, immunogens used to produce the antibodies, and immunoassay kits and methods for using the antibodies.
IMMUNOASSAYS USING ANTIBODIES SPECIFIC TO CARBAMAZEPINE
申请人:YU Liuming
公开号:US20120244557A1
公开(公告)日:2012-09-27
The present disclosure is directed to antibodies specific to carbamazepine, immunogens used to produce the antibodies, and immunoassay kits and methods for using the antibodies.
US8569000B2
申请人:——
公开号:US8569000B2
公开(公告)日:2013-10-29
US8563713B2
申请人:——
公开号:US8563713B2
公开(公告)日:2013-10-22
Antibodies specific to carbamazepine
申请人:Yu Liuming
公开号:US08563713B2
公开(公告)日:2013-10-22
The present disclosure is directed to antibodies specific to carbamazepine, immunogens used to produce the antibodies, and immunoassay kits and methods for using the antibodies.